Literature DB >> 11223251

Cytoplasmic retention of HIV-1 regulatory protein Vpr by protein-protein interaction with a novel human cytoplasmic protein VprBP.

S Zhang1, Y Feng, O Narayan, L J Zhao.   

Abstract

Vpr is an HIV-1 auxiliary regulatory protein packaged in the virion. It has been shown to enhance the nuclear transport of the HIV-1 pre-integration complex, activate transcription of cellular and viral promoters, and arrest the cell cycle at the G2/M check-point. We previously identified a cellular protein of 180 kDa (RIP) that interacted with HIV-1 Vpr specifically. We now rename this cellular protein as Vpr-binding protein, or VprBP. In this report, we describe the cloning of the VprBP cDNA that encodes 1507 aa residues and is identical to the previously cloned cDNA KIAA0800. We demonstrate that Vpr specifically interacts with recombinantly expressed VprBP in vitro as well as in vivo. Furthermore, Vpr interacts with the cellular endogenous VprBP in the context of the HIV-1 life cycle. Mutational analysis of VprBP suggests that the Vpr binding domain is located within the C-terminal half of VprBP, which has a Pro-rich domain and several Phe-x-x-Phe repeats. Subcellular fractionation studies show that both the endogenous VprBP and the adenovirus-expressed VprBP are distributed predominantly in the cytoplasmic fraction. Consistent with previous reports, the adenovirus-expressed Vpr is distributed in both the cytoplasmic and the nuclear fractions. However, when VprBP and Vpr are expressed together, Vpr is found almost exclusively in the cytoplasm. Expression of VprBP does not affect the nuclear transport of the adenoviral nuclear protein, pTP. VprBP expressed in insect cells also blocks the nuclear transport of a Vpr-GFP fusion protein, and VprBP mutants incapable of interacting with Vpr fail to block Vpr-GFP nuclear transport. We hypothesize that Vpr interaction with VprBP may cause changes in the host cell cytoplasm that affect HIV-1 pathogenesis as well as HIV-1 replication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223251     DOI: 10.1016/s0378-1119(00)00583-7

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  41 in total

1.  Proteolytic cleavage of HIV-1 GFP-Vpr fusions at novel sites within virions and living cells: concerns for intracellular trafficking studies.

Authors:  Leon Caly; David A Jans; Sabine C Piller
Journal:  J Fluoresc       Date:  2008-12-07       Impact factor: 2.217

2.  A first-in-class NAE inhibitor, MLN4924, blocks lentiviral infection in myeloid cells by disrupting neddylation-dependent Vpx-mediated SAMHD1 degradation.

Authors:  Wei Wei; Haoran Guo; Xianjun Liu; Hong Zhang; Lei Qian; Kun Luo; Richard B Markham; Xiao-Fang Yu
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

3.  HIV-1 Vpr induces the K48-linked polyubiquitination and proteasomal degradation of target cellular proteins to activate ATR and promote G2 arrest.

Authors:  Jean-Philippe Belzile; Jonathan Richard; Nicole Rougeau; Yong Xiao; Eric A Cohen
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

Review 4.  The functions of the HIV1 protein Vpr and its action through the DCAF1.DDB1.Cullin4 ubiquitin ligase.

Authors:  Laurieann Casey; Xiaoyun Wen; Carlos M C de Noronha
Journal:  Cytokine       Date:  2010-03-27       Impact factor: 3.861

5.  DCAF1 regulates Treg senescence via the ROS axis during immunological aging.

Authors:  Zengli Guo; Gang Wang; Bing Wu; Wei-Chun Chou; Liang Cheng; Chenlin Zhou; Jitong Lou; Di Wu; Lishan Su; Junnian Zheng; Jenny P-Y Ting; Yisong Y Wan
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

6.  HIV-1 Vpr hijacks EDD-DYRK2-DDB1DCAF1 to disrupt centrosome homeostasis.

Authors:  Delowar Hossain; Jérémy A Ferreira Barbosa; Éric A Cohen; William Y Tsang
Journal:  J Biol Chem       Date:  2018-05-03       Impact factor: 5.157

Review 7.  Accessories to the crime: recent advances in HIV accessory protein biology.

Authors:  Thomas Gramberg; Nicole Sunseri; Nathaniel R Landau
Journal:  Curr HIV/AIDS Rep       Date:  2009-02       Impact factor: 5.071

8.  Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1/K2 transcription factors.

Authors:  Jessica Komorek; Mohan Kuppuswamy; T Subramanian; S Vijayalingam; Elena Lomonosova; Ling-Jun Zhao; Joe S Mymryk; Kimberly Schmitt; G Chinnadurai
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

9.  Anti-cancer effect of HIV-1 viral protein R on doxorubicin resistant neuroblastoma.

Authors:  Richard Y Zhao; Dong Liang; Ge Li; Christopher W Larrimore; Bernard L Mirkin
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

10.  CAPIH: a Web interface for comparative analyses and visualization of host-HIV protein-protein interactions.

Authors:  Fan-Kai Lin; Chia-Lin Pan; Jinn-Moon Yang; Trees-Juen Chuang; Feng-Chi Chen
Journal:  BMC Microbiol       Date:  2009-08-12       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.